No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RMD241220P230000
- 1.00
- -0.77-43.50%
15min DelayClose Dec 19 16:00 ET
2.50High1.00Low
2.45Open1.77Pre Close260 Volume891 Open Interest230.00Strike Price50.56KTurnover77.93%IV1.11%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry1.00Extrinsic Value100Contract SizeAmericanOptions Type-0.3858Delta0.0666Gamma147.03Leverage Ratio-3.0343Theta-0.0009Rho-56.73Eff Leverage0.0282Vega
Intraday
- 5D
- Daily
News
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing
With 74% Institutional Ownership, ResMed Inc. (NYSE:RMD) Is a Favorite Amongst the Big Guns
We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease
This AutoZone Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Stifel Maintains ResMed(RMD.US) With Hold Rating, Maintains Target Price $250
ResMed Analyst Ratings